Factory 99% Entecavir Powder CAS 142217-69-4 Chemical Intermediate Entecavir

• Customization: Available
• Powder: Yes
• Customized: Customized
• Model NO.: A870
• Certification: GMP, HSE, ISO 9001, USP, BP
• Suitable for: Elderly, Children, Adult
• State: Powder
• Purity: >99%
• Name: Entecavir
• CAS: 142217-69-4
• Appearance: White Powder
• Assay: 99%
• OEM: Available
• Sample: Available
• Suitable: Adult
• MOQ: 1g
• Function: Chemical Intermediate
• Transport Package: Foil Bag
• Specification: 99
• Trademark: /
• Origin: China
• Production Capacity: 10000 Kgs Per Month

Product Description

 

Product Name	Entecavir
Appearance	White Powder
CAS NO.	142217-69-4
Storage	Keep in a cool, dry, dark location

 

Entecavir is defined as a nucleoside analogue drug specifically designed for the treatment of chronic hepatitis B virus (HBV) infection. Below is a concise description of its applications and functions:

 

1. Primary Treatment for Chronic HBV: Entecavir is primarily used as a first-line treatment option for patients with chronic hepatitis B, aiming to suppress viral replication and reduce liver damage.
2. Management of HBV in Special Populations: It is also utilized in specific patient populations, such as those with cirrhosis, liver transplantation candidates, and those co-infected with HIV.
3. Part of Combination Therapy: In some cases, Entecavir may be used in combination with other antiviral agents to enhance therapeutic outcomes.

1. Inhibition of HBV Replication: Entecavir functions by inhibiting the activity of HBV polymerase, a key enzyme involved in viral replication. This leads to a significant reduction in viral load, thereby controlling disease progression.
2. Improvement of Liver Function: By suppressing viral replication, Entecavir helps to improve liver function and reduce the risk of liver-related complications, such as cirrhosis and hepatocellular carcinoma.
3. Low Resistance Rate: Compared to other antiviral agents, Entecavir has a relatively low resistance rate, making it a durable treatment option for chronic HBV patients.